Thanks to support from companies in the health care industry, the 2019 AANP National Conference is able to offer complimentary access to non-CE Product Theaters (PTs) for registered conference attendees. PTs are educational presentations, which may be branded and are usually sponsored using marketing funds from health care industry companies.
The occurrence of these PTs and the presentation of industry sponsored information at the 2019 AANP National Conference does not constitute an AANP product endorsement.
Regulations and Restrictions
Some states have passed regulations requiring the industry to track and report the value of gifts to health care providers from industry marketing and have also placed restrictions on certain employment settings. In obeying these state regulations and restrictions, the sponsor may choose at their discretion to restrict access to health care provider attendees from specific states. Their reports must contain the value of each meal and the recipient's name and contact information. If you attend the PT, you are providing permission for AANP to release your contact information (name, mailing address, phone number, email address and other information as requested) to the event sponsor and their organizing company for the purpose of meeting various state reporting requirements and sending attendees related event product updates.
AANP will assist in notifying registered conference attendees from the states or employment settings that are not eligible to attend PTs if information regarding restrictions is provided by the sponsor. The sponsor's signage will also be featured near the event entrance, indicating any states and employment settings restricted from attending the industry sponsored non-CE PT event.
Registration and Admission
Due to their educational focus, attendance is limited. Restrictions apply. PTs are only open to registered conference attendees. Registration and admission will occur at the entrance of each scheduled event on a first come, first served basis. You must have your conference name badge with you to be scanned for admission. There will be no pre-registration.
19.2.121 Practical Approaches to Optimal COPD Management
19.2.123 Lower Together: LDL-C, Risk, Hassle, Cost
19.2.124 Expert Conversations in Heart Failure
19.2.195 Is GLP-1 Activity Insufficient in T2D?a
19.2.196 Screening and Diagnosing Binge Eating Disorder in Adult Patients
19.3.005 Opioid Therapy Insights: A Holistic Approach to Managing Patients
19.3.100 Selecting A First-Choice Therapy For Systolic HF: The Growing Body of Evidence
19.3.101 IPF/OFEV Pulmonary Fibrosis
19.3.102 What You Need to Know About Migraine Burden, Diagnosis and Treatment
19.3.103 Prevention of Seasonal Influenza: Making the Case for Cell-based Vaccines
19.3.104 Chronic Pain: Unmet Need, New Frontiers
19.3.185 NUPLAZID® (pimavanserin) 34 mg: The First and Only FDA-Approved Treatment for Delusions and Hallucinations with Parkinson's Disease Psychosis
19.3.186 COPD: Simplifying a Complex Paradigm for Clinicians
19.4.005 - TBD
19.4.106 - RYTARY in Clinical Practice – A Case-Based Approach
19.4.108 An Alternative Option for the Management of Chronic Pain
19.4.109 JARDIANCE Data From the Comprehensive Clinical Development Program
19.4.110 Are We Doing All We Can to Help Reinforce Recovery?
19.4.150 Criticality of LDL-C Lowering: A Focus on New Cholesterol Management Guidelines
19.5.005 Trokendi XR: Expanding on the Rich History of Topiramate
19.5.079 Treatment for Patients with Acute Coronary Syndrome or Prior Myocardial Infarction
19.5.081 A Migraine Preventive Treatment for Adults
19.5.082 Evidence-Based Approach to Anticoagulation Therapy for CAD/PAD